ATE348184T1 - Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere - Google Patents

Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere

Info

Publication number
ATE348184T1
ATE348184T1 AT01918350T AT01918350T ATE348184T1 AT E348184 T1 ATE348184 T1 AT E348184T1 AT 01918350 T AT01918350 T AT 01918350T AT 01918350 T AT01918350 T AT 01918350T AT E348184 T1 ATE348184 T1 AT E348184T1
Authority
AT
Austria
Prior art keywords
human
genetic modification
sperm dna
dna preparations
human animals
Prior art date
Application number
AT01918350T
Other languages
English (en)
Inventor
Kangsheng Wang
Original Assignee
Bioagri Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioagri Corp filed Critical Bioagri Corp
Application granted granted Critical
Publication of ATE348184T1 publication Critical patent/ATE348184T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/061—Sperm cells, spermatogonia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01918350T 2000-03-28 2001-03-05 Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere ATE348184T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/537,861 US7067308B1 (en) 2000-03-28 2000-03-28 Vector for genetically modifying non-human animals

Publications (1)

Publication Number Publication Date
ATE348184T1 true ATE348184T1 (de) 2007-01-15

Family

ID=24144410

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918350T ATE348184T1 (de) 2000-03-28 2001-03-05 Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere

Country Status (10)

Country Link
US (2) US7067308B1 (de)
EP (2) EP1268836B1 (de)
JP (1) JP2003528617A (de)
CN (1) CN1432067A (de)
AR (1) AR028298A1 (de)
AT (1) ATE348184T1 (de)
AU (1) AU2001245438A1 (de)
DE (1) DE60125156T2 (de)
PE (1) PE20011214A1 (de)
WO (1) WO2001073094A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053187B2 (en) 2000-03-28 2006-05-30 Gioagri Corporation Sperm-specific monoclonal antibody, mAbC
US7067308B1 (en) * 2000-03-28 2006-06-27 Bioagri Corporation Vector for genetically modifying non-human animals
US7527966B2 (en) 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
NZ581542A (en) * 2007-05-16 2012-02-24 Mat Malta Advanced Technologies Ltd Treatment and prevention of influenza
WO2010036976A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
JP5964746B2 (ja) * 2009-04-08 2016-08-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｄｎａ−細胞コンジュゲート
US9150881B2 (en) 2009-04-09 2015-10-06 Proteovec Holding, L.L.C. Production of proteins using transposon-based vectors
CN102453720B (zh) * 2010-10-28 2013-01-30 华中农业大学 一种在猪肌肉组织高效表达的融合启动子
SMT202200205T1 (it) * 2011-10-28 2022-07-21 Regeneron Pharma Topi geneticamente modificati che esprimono molecole chimeriche del complesso maggiore di istocompatibilità (mhc) ii
US20150024497A1 (en) * 2013-07-19 2015-01-22 Elwha Llc Methods and Systems for Utilizing Sperm for Molecular Delivery
CA3065317A1 (en) 2017-05-31 2018-12-06 Commonwealth Scientific And Industrial Research Organisation Trait selection in avians

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428132A (en) 1987-10-11 1995-06-27 United States Of America Conjugate and method for integration of foreign DNA into cells
IT1228210B (it) 1989-01-10 1991-06-05 Consiglio Nazionale Ricerche Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali.
IL92529A0 (en) 1989-12-03 1990-08-31 Yissum Res Dev Co Generation of transgenic vertebrates by employing transformed sperm cells via artificial insemination
US5521291A (en) 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
AU2146092A (en) 1992-05-28 1993-12-30 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
RU2081914C1 (ru) 1994-07-21 1997-06-20 Андрей Вадимович Кузнецов Способ введения чужеродной днк в сперматозоиды
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
JPH10304790A (ja) 1995-09-29 1998-11-17 Hoechst Japan Ltd トランスジェニック動物の作成方法
CN1112165C (zh) 1997-08-15 2003-06-25 中国农业大学 精子介dna转移生产转基因动物的方法
KR20010033162A (ko) 1998-01-28 2001-04-25 오미야 히사시 생식세포로의 유전자 도입법
EP1053340A4 (de) 1998-02-09 2003-04-09 Tranxenogen Inc Genetische manipulation von spermatogonien
IL123411A0 (en) 1998-02-22 1998-09-24 Kimron Veterinary Inst High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
CA2340242A1 (en) 1998-08-11 2000-02-24 Teruhiko Wakayama Method of performing transgenesis
US7053187B2 (en) * 2000-03-28 2006-05-30 Gioagri Corporation Sperm-specific monoclonal antibody, mAbC
US7067308B1 (en) * 2000-03-28 2006-06-27 Bioagri Corporation Vector for genetically modifying non-human animals

Also Published As

Publication number Publication date
EP1268836B1 (de) 2006-12-13
PE20011214A1 (es) 2001-11-29
US7067308B1 (en) 2006-06-27
CN1432067A (zh) 2003-07-23
EP1268836A2 (de) 2003-01-02
US20070214512A1 (en) 2007-09-13
AU2001245438A1 (en) 2001-10-08
EP1760155A2 (de) 2007-03-07
EP1760155A3 (de) 2007-03-14
DE60125156D1 (de) 2007-01-25
JP2003528617A (ja) 2003-09-30
AR028298A1 (es) 2003-04-30
WO2001073094A3 (en) 2002-05-30
DE60125156T2 (de) 2007-09-20
WO2001073094A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2001269936A1 (en) Transgenic algae for delivering antigens to an animal
ATE348184T1 (de) Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere
SI1520008T1 (sl) Mediji brez Ĺľivalskih proteinov za kultiviranje celic
IS6316A (is) Aðferð til erfðafræðilegra greininga
AU2013202A (en) Nucleic acid amplification methods
EP1594956A4 (de) System zur expression von genen in pflanzen
DE60143301D1 (de) Polyarylcarboxamide zur verwendung als lipidsenker
IL153906A0 (en) Method for direct genetic analysis of target cells
DE69937732D1 (de) Biosynthetische gene zur spinosyn-insektizidherstellung
AU782154C (en) DNA vaccines for pets and sport animals
EP1452093A4 (de) Chimäres nichtmenschliches tier
NO20020566L (no) Avfallseparasjonssystem for fiskemerder
GB0026424D0 (en) Genetic analysis of microorganisms
FR2776928B1 (fr) Vaccins adn adjuves
EP1611249A4 (de) Oligoribonukleotide und ribonukleasen für rna-spaltung
FR2804028B1 (fr) Vaccins adn ameliores pour animaux de rente
DE60100554D1 (de) Katzenstreubehälter
DE60141221D1 (de) Verfahren zur genexpressionsanalyse
DE60126023D1 (de) System zur Durchführung sequentieller Reaktionen
DE60117297D1 (de) Genetischer test zur identifizierung von trägern komplexer vertebraler missbildungen in rindern
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
EP1446488A4 (de) Reguliertes nukleinsäureexpressionssystem
EP1818406A4 (de) Genkonstruktion, vektor und dna-impfstoff zur impfung von im wasser lebenden tieren
DE60236511D1 (de) Biosynthetische gene zur herstellung von butenyl-spinosyn-haltigem insektizid
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties